COPSAC COPSAC COPSAC COPSAC
  • About COPSAC
    • About
    • Organization Diagram
    • Board of Directors
    • Research team
    • Location
    • Funding
    • Logo
    • Open positions
  • COPSAC cohorts
    • COPSAC2000 cohort
    • COPSAC2010 cohort
    • COPSACSEVERE cohort
    • COPSACACUTE cohort
    • Methods
    • Data overview
      • COPSAC2000 Clinic
      • COPSAC2000 Exposures
      • COPSAC2000 Omics
      • COPSAC2000 Biobank
      • COPSAC2010 Clinic
      • COPSAC2010 Exposures
      • COPSAC2010 Omics
      • COPSAC2010 Biobank
  • Dissemination
    • Theses
    • Literature for parents
  • Research Projects
    • RestoreGut
    • COPSYCH Research Alliance
    • HEDIMED Consortium
    • EDIAQI Consortium
    • EAGLE Consortium
    • EarlyVir
  • Strategy
  • ‌

2018 Nadia Rahman Fink, MD

  • 2015 Ann-Marie Malby Schoos, MD PhD
    • Thesis_2015_Ann-Marie_Schoos
  • 2014 Marie Kragh, MSc PhD
    • Thesis_2014_Marie-Kragh.pdf
  • 2014 Eskil Kreiner-Møller, MD PhD
    • Thesis_2014_Eskil-Kreiner-Moller
  • 2014 Nadja Hawwa Vissing, MD PhD
    • Thesis_2014_Nadja-Vissing
  • 2014 Anna Hammerich Thysen, Msc PhD
    • Thesis_2014_Anna-Thysen
  • 2013 Charlotte Giwercman Carson MD, PhD
    • Thesis_2013_Charlotte-Giwercman
  • 2013 Anne Louise Bischoff MD, PhD
    • Thesis_2013_Anne-Bischoff
  • 2012 Louise Pedersen, MD, PhD
    • Thesis_2012_Louise-Pedersen
  • 2012 Jakob Stokholm, MD, PhD
    • Thesis_2012_Jakob-Stokholm
  • 2012 Nilofar Følsgaard, MD, PhD
    • Thesis_2012_Nilo-Foelsgaard
  • 2011 Martin Brasholt, MD, PhD
    • Thesis_2011_Martin-Brasholt
  • 2011 Bo Chawes, MD, PhD
    • Thesis_2011_Bo-Chawes
  • 2010 Klaus Bønnelykke, MD, PhD
    • Thesis_2010_Klaus-Bonnelykke
  • 2010 Porntiva Poorisrisak, MD, PhD
    • Thesis_2010_Porntiva-Poorisrisak
  • 2009 Mette N Hermansen, MD, PhD
    • Thesis_2009_Mette-Hermansen
  • 2006 Liselotte B Halkjær, MD, PhD
    • Thesis_2006_Liselotte-Halkjær
  • 2006 Birgitte Boysen Kjær, MD, PhD
  • 2004 Lotte Loland, MD, PhD
    • Thesis_2004_Lotte-Loland
  • 2002 Frederik F Buchvald, MD, PhD
    • Thesis_2002_Frederik-Buchvald
  • 1999 Marianne Stubbe Østergaard, MD, PhD
  • 1993 Jytte Fogh, MD, PhD
  • 2017 Elín Bjarnadóttir, MD PhD
  • 2017 Helene Wolsk, MD
  • 2017 Tine Marie Pedersen, MD
  • 2017 Astrid Sevelsted, MSc
  • 2017 Rebecca Kofod Vinding, MD
  • 2019 Lambang Arianto, MD
  • 2018 Henrik Hallas, MD
  • 2018 Jonathan Thorsen, MD
  • 2018 Nadia Rahman Fink, MD
  • 2019 Christian Carlsson, MD
  • 2019 Christian Carlsson, MD
  • 2019 Ni Wang, MD
  • 2021 Sarah Nørgaard – MSc
  • 2020 Asja Kunøe – MD
  • 2021 Nicklas Brustad – MD
  • 2021 Anders Eliasen – MSc
  • 2021 Lærke Sass – MD
  • 2022 Pia Nørrisgaard – MSc
  • 2022 Emil Christensen – MD
  • 2023 Rikke Sunde – MD
  • 2023 Julie Kyvsgaard – MD
  • 2024 Yang Luo – MSc
  • 2024 Julie Rosenberg – MD
  • 2024 Christina Poulsen – MSc
  • 2024 Parisa Mohammadzadeh – MD
  • 2024 Signe Jensen – MD
  • 2024 David Horner – MD
  • 2025 Liang Chen
Home Home Dissemination Theses 2018 Nadia Rahman Fink, MD

Low-grade Inflammation in Childhood

By Nadia Rahman Fink

Summary

Chariman: Klaus Müller

Opponent: Erik Melén

Opponent: Maria Jenmalm

ABSTRACT

Elevated level of high sensitivity C-reactive protein (hs-CRP) is a marker of a low-grade inflammation and is associated with a range of chronic inflammatory diseases, including asthma and allergy. Hs-CRP has been associated with obesity, metabolic syndrome and cardiovascular disease, consequently exercise, diet and weight reduction have been proposed to alter level of inflammation – suggesting an extrinsic environmental influence. Most studies on childhood low-grade inflammation have been done in school- age children; still data from early life is ambiguous and sparse.

In pregnancy increased levels of hs-CRP is associated with obesity and pregnancy related conditions such as preeclampsia and gestational diabetes. During normal pregnancy maternal immunity is altered, and an anti-inflammatory environment is induced. Conversely CRP seems to be elevated during normal pregnancy but is not transferred directly across the placenta.

Only very little is known about the transfer of low-grade inflammation from mother to child. Genetic predisposition to inflammatory diseases is well known, and the heritability of hs-CRP level is estimated to be 25-45%. In line with this Genome Wide Associations Studies have found several Single Nucleotide Polymorphisms to be closely associated with CRP levels in adults, but only a minor part of the variance of CRP levels can be explained by these genetic factors. Accordingly intrauterine programming as well as environmental factors including the human microbiota has been speculated as facilitators of systemic low-grade inflammation in childhood.

The human microbiota consists of an ecological community of microorganism including bacteria, living in and on the human body. The human microbiota has become increasingly recognized as a relevant area of interest with potential immune modulatory effects, through active metabolites and direct microbe-host interactions. Pathogenic bacteria of the airways have already been proven connected to later development of childhood asthma. Airway microbial immune interactions could be a potential disease- mechanism in later development of inflammatory disease.

Objectives: To investigate development of systemic low-grade inflammation in early childhood, and specific host, genetic and environmental risk-factors.
This PhD consists of two studies:

Paper I: The aim of this study was to investigate the influence of airway microbiota on early life systemic inflammation. We examined whether the composition of three known pathogenic airway bacteria; Moraxella catarrhalis, Haemophilus influenzae and Streptococcus pneumoniae were associated with early life systemic low-grade inflammation in the COPSAC2010 cohort, and the high risk COPSAC2000 cohort.
In the COPSAC2010 cohort we found that pathogenic airway bacterial colonization age 1 and 3 months, was associated with levels of low-grade inflammation age 6 months. Prior infections and siblings at home were also found to influence levels of low-grade inflammation. The findings were replicated in the COPSAC2000 cohort, and further supported by a joined analysis of both cohorts. The conclusion of this study was that; asymptomatic neonates colonized with M. catarrhalis, H. influenzae and/or S. pneumoniae have elevated levels of systemic low-grade inflammation age 6 months.
Paper II: The aim of this study was to investigate if systemic low-grade inflammation tracks from mother to child. Investigations were done in the COPSAC2010 birth cohort, investigating levels of hs-CRP from mothers’ week 24 of pregnancy and week 1 post- partum in relation to levels of hs-CRP in their children age 6 months. We further investigated how anthropometric, genetic and environmental factors could determine levels of hs-CRP in mother and child. Smoking during pregnancy, high BMI, use of antibiotics, season and level of social circumstances were associated hs-CRP in the pregnant mothers. We found a CRP Genetic Risk Score significantly associated with increased levels of hs-CRP in the children, and moreover siblings, infections, BMI and airway bacteria likewise associated with increased levels of hs-CRP.
The conclusion of this study was that; levels of hs-CRP strongly correlated between pregnant mothers and their children, independently of the genetic, anthropometric and environmental risk factors investigated.

In conclusion: The two studies imply that elevated levels of low-grade inflammation may be a trait present in healthy neonates, determined very early in life and possibly induced by a combination of hereditary factors, fetal programming and early life environmental exposures including colonization with pathogenic airway bacteria.


CONTACT

COPSAC
Copenhagen Prospective Studies on Asthma in Childhood
Copenhagen University Hospital, Herlev-Gentofte
phone +45 3867 7360
contact@copsac.com
COPSAC • Copenhagen University Hospital, Herlev-Gentofte • Denmark © 2023
  • About COPSAC
    • About
    • Organization Diagram
    • Board of Directors
    • Research team
    • Location
    • Funding
    • Logo
    • Open positions
  • COPSAC cohorts
    • COPSAC2000 cohort
    • COPSAC2010 cohort
    • COPSACSEVERE cohort
    • COPSACACUTE cohort
    • Methods
    • Data overview
      • COPSAC2000 Clinic
      • COPSAC2000 Exposures
      • COPSAC2000 Omics
      • COPSAC2000 Biobank
      • COPSAC2010 Clinic
      • COPSAC2010 Exposures
      • COPSAC2010 Omics
      • COPSAC2010 Biobank
  • Dissemination
    • Theses
    • Literature for parents
  • Research Projects
    • RestoreGut
    • COPSYCH Research Alliance
    • HEDIMED Consortium
    • EDIAQI Consortium
    • EAGLE Consortium
    • EarlyVir
  • Strategy
  • ‌
COPSAC